BERTELE', Anna
 Distribuzione geografica
Continente #
NA - Nord America 638
AS - Asia 426
EU - Europa 362
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.448
Nazione #
US - Stati Uniti d'America 629
CN - Cina 253
IE - Irlanda 142
SE - Svezia 131
SG - Singapore 119
TR - Turchia 35
IT - Italia 20
CI - Costa d'Avorio 18
FI - Finlandia 17
DE - Germania 13
CA - Canada 9
BE - Belgio 8
IN - India 8
RU - Federazione Russa 6
NL - Olanda 5
EU - Europa 4
GB - Regno Unito 4
RO - Romania 4
ID - Indonesia 3
IR - Iran 3
KR - Corea 3
LT - Lituania 3
BG - Bulgaria 2
HU - Ungheria 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
FR - Francia 1
JP - Giappone 1
NO - Norvegia 1
PH - Filippine 1
Totale 1.448
Città #
Chandler 208
Dublin 142
Singapore 106
Ashburn 48
Nanjing 48
Shanghai 42
Dearborn 40
Beijing 33
Izmir 30
Boardman 25
Princeton 25
Ann Arbor 18
Abidjan 17
Wilmington 16
Shenyang 14
Nanchang 13
Changsha 12
Helsinki 12
Jiaxing 12
Jinan 11
Tianjin 11
New York 10
San Mateo 9
Hefei 8
Pune 8
Santa Clara 8
Kunming 7
Ottawa 7
Hebei 6
Los Angeles 6
Brussels 5
Chengdu 5
Jacksonville 5
Kocaeli 5
Norwalk 5
Fryazino 4
Hangzhou 4
Ningbo 4
Timisoara 4
Woodbridge 4
Andover 3
Bandung 3
Bremen 3
Cambridge 3
Geumcheon-gu 3
Milan 3
Shijiazhuang 3
Zanjan 3
Arnhem 2
Bologna 2
Budapest 2
Castelnuovo Rangone 2
Chongqing 2
Dallas 2
Frankfurt am Main 2
Grafing 2
Jiangnong 2
Montegaldella 2
Moscow 2
Opera 2
Parma 2
Redwood City 2
Rockville 2
Seattle 2
Sofia 2
Taiyuan 2
Toronto 2
Baotou 1
Borås 1
Clifton 1
Des Moines 1
Edinburgh 1
Glasgow 1
Guangzhou 1
Harbin 1
Huizen 1
Lanzhou 1
London 1
Lottstetten 1
Munich 1
Olomouc 1
Oslo 1
Quezon City 1
Quzhou 1
Redmond 1
Wenzhou 1
Wuhan 1
Totale 1.079
Nome #
Kleine-Levin syndrome: the contribution of PET scan and hydrogen breath test for small intestinal bacterial overgrowth 87
Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? 76
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 72
P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients 69
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 68
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 68
P.01.13: Gastrin-17 as a Non-Invasive Marker for Gerd: A Prospective Study on Sample of 777 Consecutive Patients 64
Organization of a high quality endoscopic unit: The experience of parma 64
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 62
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 62
Serum pepsinogen II for early assessment of success of H. pylori eradication 61
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 59
Gastro panel® for detection of atrophic gastritis: The “Parma model” 58
OC.18.1 ARE ALL PATIENTS WITH HISTOLOGICAL DIAGNOSIS OF ATROPHIC GASTRITIS REALLY AT RISK OF DEVELOPING GASTRIC CANCER? ASSESSMENT OF GASTRIC ACID PRODUCTION BY CORRELATION BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I 58
P.01.11: Gastrin 17 in Singling out Patients with Different Pattern of Gastroesophageal Reflux: A Pilot Study using PH-Impedance as Reference Standard 57
S2067 A Comparison Between Lactose Breath Test and a Quick Test On Duodenal Biopsies for Lactase Deficiency, in Patients with a Self Reported Lactose Intolerance 56
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 56
P.01.8: Gerd Risk Factors in Different Epidemiological Settings: Results from a Structured Questionnaire on a Sample of 545 People 54
Sa1862 Are All Patients With Histological Diagnosis of Atrophic Gastritis Really At Risk of Developing Gastric Cancer? Assessment of Gastric Acid Production by Correlation Between Maximal Acid Output and Pepsinogen I 54
DO PREBIOTICS RELIEVE CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) SYMPTOMS? A RANDOMIZED SINGLE BLINDED STUDY 53
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 50
Non invasive diagnosis of upper GI disease in a primary care setting: A study on 1900 patients 48
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 44
CORRELATION BETWEEN LACTOSE H2-BREATH TEST AND CLINICAL DATA: IS IT POSSIBLE TO SELECT PATIENTS WHO NEED LACTOSE BREATH TEST? 42
Raising public awareness of GI disease: An innovative strategy for a national campaign 32
Totale 1.474
Categoria #
all - tutte 6.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020124 0 0 0 0 6 44 28 10 12 18 3 3
2020/202126 1 1 5 0 1 0 3 2 4 6 3 0
2021/2022106 1 0 0 3 13 2 1 8 5 12 9 52
2022/2023591 46 67 51 55 38 71 1 49 186 5 21 1
2023/2024207 5 27 4 4 21 51 8 18 16 11 20 22
2024/2025175 24 29 36 29 57 0 0 0 0 0 0 0
Totale 1.474